IgG-single-chain TRAIL fusion proteins for tumour therapy
Martin Siegemund(University of Stuttgart), Roland E. Kontermann(University of Stuttgart), Meike Hutt(University of Stuttgart), Oliver Seifert(University of Stuttgart), F Schneider(University of Stuttgart), Dagmar Kulms(National Center for Tumor Diseases), Klaus Pfizenmaier(University of Stuttgart), Ines Müller(Mount Sinai Hospital)
Cited by 28
Related Papers
Lack of beta-arrestin signaling in the absence of active G proteins
|Nature Communications|2018|382
Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation
|Human Mutation|2007|288
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
|Frontiers in Cell and Developmental Biology|2020|240